Vis enkel innførsel

dc.contributor.authorGu, Shangyan
dc.contributor.authorLu, Yu
dc.contributor.authorWang, Yuji
dc.contributor.authorLu, Wensheng
dc.contributor.authorWang, Wei
dc.date.accessioned2023-04-24T10:48:30Z
dc.date.available2023-04-24T10:48:30Z
dc.date.created2023-04-03T12:59:35Z
dc.date.issued2023
dc.identifier.issn1999-4923
dc.identifier.urihttps://hdl.handle.net/11250/3064474
dc.description.abstractOctadecylazanediyl dipropionic acid (C18ADPA) is a zwitterionic amphiphile with a dendritic headgroup. C18ADPA self-assembles to lamellar networks, which encompasses water and forms a low-molecular-weight hydrogel (LMWG). In this study, we use the C18ADPA hydrogel as a drug carrier for the in vivo delivery of a copper salt for wound healing in a mouse model. A structural transition was observed based on cryo-scanning electron microscope (cryo-SEM) images after drug loading. The C18ADPA hydrogel, which had a layered structure, transformed into a self-assembled fibrillar network (SAFiN). The mechanical strength of the LMWG has always been an important issue in its applications. However, due to the structural transition, both the storage and loss moduli increased. In vivo tests showed that wound closure was faster after applying the hydrogel formulation compared with the Vaseline formulation. For the first time, we have also provided histological evidence of these effects on skin tissue. The hydrogel formulation exhibited clear advantages in regenerating tissue structure over traditional delivery formulations.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleLow Molecular Weight Hydrogel for Wound Healingen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.source.articlenumber1119en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.3390/pharmaceutics15041119
dc.identifier.cristin2139235
dc.source.journalPharmaceuticsen_US
dc.identifier.citationPharmaceutics. 2023, 15, 1119.en_US
dc.source.volume15en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal